InvestorsHub Logo
Followers 4
Posts 1860
Boards Moderated 0
Alias Born 02/07/2014

Re: None

Saturday, 02/09/2019 12:14:28 AM

Saturday, February 09, 2019 12:14:28 AM

Post# of 194795
Class actions arent classy wonder if every shareholder (supposed to be 25,000 according to cen bio website sent in and asked for some information if they would respond and we would hear the end of this class action stuff

Questions for Bill Chabaan and other officers of company associated with, spin off or created as a result of an initial investment in CEN Biotech.

1. When is our ticker going to be trading? If unknown, what is the plan to make this happen? What are the obstacles? Where are we in this process?
2. I'm curious about the insurance aspect with wmpj: Can you elucidate plans, opportunities, setbacks or obstacles?
3. Regarding the Nubreed acquisition: What are the plans with this acquisition?
4. Is there a plan to file a single or multiple an S-1’s? If yes, when? What are the obstacles?
5. What are the plans for Cen Biotech Ukraine as it relates to shareholders of the original CEN Biotech Investment?
6. What are the company plans to become a publicly traded company? As much detail as possible please?
7. Do we have any applications in to grow medical marijuana or hemp in North America or are we currently growing medical marijuana or hemp in North America?
8. Our earnings reports suggest we are not producing little if any revenue. What are the company plans to produce revenue and in what time frame do you hope to achieve this?
9. How was this quiet period strategy conjured up? Who conjured it up and signed off on it?
10. What happened to John Gerimano (spelling)?
11. Are you worried about the Russians sabotaging us in Ukraine? How would CEN Biotech Ukraine be affected by a Russian invasion for war?
12. What’s the statute of limitations for the Ontario superior case? What phase are we in?
13. Were we able to take advantage of the Cufta trade act Ukraine shares with Canada?
14. How come The Edge stores have not been repurposed to possibly sell retail cannabis or turn them into a dispensary?
15. When's the date Jeff and Nubreed come back under Cen Biotech umbrella and will they launch a hemp energy drink to be sold in the edge nutrition stores?
16. When & who was it that agreed that James L Robinson was the man to take over FITX creative edge? Was it Bill alone or was Jeff involved in the decision making on the transition process?
17. What is happening to the FPFI shares?
18. If Bill and company are growing hemp (they have for 2016 and 2017 and 2018), are Cen Bio shareholders entitled to know business dealings?
19. What can we do as shareholders to try to see something happen with our stock ownership? Shouldn't we be entitled to financial reports? With all the spinoffs it is hard to keep track of what or who owns what.
20. What if fitx gets delisted and they say the spinoff wasn't done right what happens to us?

21. What was the date that the decision to drop the nafta case was made on? Who decided that decision? Why weren't shareholders properly notified?

22. How long are shareholders supposed to hold on only getting company news through gossip on facebook in investor groups and in private messages?

23. What's the plan? In no way would this be asking too much at this stage. The silence from HQ is deafening?

24. Can someone please update the shareholders who aren’t ‘whales’ or ‘insiders’?

25.Also the shareholders that claim to be insiders on facebook have their NDAS produced so we know who's credible with their predictions & speculations?

26. How many NDAS are in circulation?

26. When will be the companies first product launch be celebrated?

27. Who wrote this? ( There are too many variables to determine long term PPS. Short term at announcement of MMPR license PPS can spike in a "range" from PPS at time of announcement up to $.50 (yes or higher) and even much higher but no higher than .80. These factoring bound variable fall with different categories: after license announcement, the momentum of the stock will have a major "uncontrollable" upswing due to months of accumulation by the retail investors "us". Insiders have a strong hold of 80-85% of the outstanding shares. Open market shares will be limited. Bound variables are the following: 1) License for bldg 1 2) License for bldg1 & 2 3) License for bldg 1 & 2 site 1, and bldg 1 & 2 site 2 with commercial hemp production license. *Mere license news will create a stock momentum of .20-.30 range. As you select the higher bound variable above the higher the PPS, capping at .80. The following immediate announcements will
affect the PPS to break the resistance of .80 and push PPS above $1 to a new cap range of $2 would be any of the following announcements in any order and combination of: 1) Immediate hemp product on site 1 & 2 and addition discloser of lot 3 (25 acres). 2) International hemp production update with positive cash flow announcement 3) Announcement of contract or LOI with major hemp industry player for any of the 20-30 hemp by-products 2) Uplisting - Deloitte audit has been completed & validated. 3) partnership with "X" company for MMJ or hemp 4) Merger of RXNB & FITX to include private holdings: a) Brooklyn Pharma b) Craexis c) Jade Medical d) Mineovor e) Open Pharma f) Techdyne Software g) WMPG h) Xena ^last state